Abeona Therapeutics Inc. (NASDAQ: ABEO) had its price target increased by equities researchers at Maxim Group from $0.00 to $8.00. With a rating of on the shares, the company has a 52-week high of $6.74. As a means of comparison, a number of other analysts have spoken on the stock recently, and the company has earned a consensus one-year price target of $14.70, above the opening price of $6.01.
The Fed stood pat on interest rates on Wednesday, helping stocks to mostly higher levels but Chairwoman Janet Yellen indicated an interest rate hike is likely by year’s end
On Wednesday, the S&P 500 SPX, +1.09% ended 1.1% higher, while the Dow DJIA, +0.90% jumped by 0.9%, or 164 points, as each exchange finished in positive territory for a second consecutive day.
The tech-heavy Nasdaq Composite COMP, +1.03% tacked on 1% and scored a record closing high.
S&P 500 futures ESZ6, +0.36% were up 6.55 points, or 0.3%, to 2,162.75 early Thursday, while Dow Jones Industrial Average futures YMZ6, +0.37% rose 58 points, or 0.3%, to 18,276. Nasdaq-100 futures NQZ6, +0.39% gained 16.25 points, or 0.3%, to 4,866.25.
Yesterday Abeona Therapeutics Inc. (NASDAQ: ABEO) shares last traded at $6.57, which represents a spike of $0.79 from the previous closing price. Opening at $6.01, they ranged from $5.69 and $6.74 throughout the day.
Abeona Therapeutics Inc. (NASDAQ: ABEO) now has a market cap of 220.39M.
1,361,685 shares traded hands yesterday, above normal, out of a total float 15,682,000. Considerable volume aggregation by institutional investors may be on the horizon as the combination of large expansions in trading volume and price inflation can be indicative components.
As with all possible breakouts, investors look for volume to be at least 40%-50% greater than normal on the breakout to show that fund managers and other professional investors are jumping in.
Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.
Professional investors such as these have teams of analysts researching thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.
By tracking the activity of these professional investors and how they affect moving averages,it allows for traders to make more impactful choices on trades.
Trades for Abeona Therapeutics Inc. (NASDAQ: ABEO) have ranged from $2.05 – 6.74, and the stock now has a 50-day MA of $4.38 and 200-day MA of $3.11. Today’s last price is 0.03% under the 52 week high of $6.74.
Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors watch for companies that have grown their earnings at least 25% or more over 3 consecutive years.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.